A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis
Latest Information Update: 31 Jul 2023
At a glance
- Drugs Estradiol/norethisterone (Primary) ; Linzagolix (Primary)
- Indications Endometriosis; Pain
- Focus Registrational; Therapeutic Use
- Sponsors Bio Genuine
Most Recent Events
- 25 Jul 2023 Status changed from not yet recruiting to recruiting.
- 13 Jun 2023 New trial record